Ruby J. Siegel completed her PhD in pharmaceutical sciences and molecular medicine at Washington State University in Spokane, WA. After earning a BS in Biology from Gonzaga University, she earned a M.Sc. in Biology/Biotechnology from Eastern Washington University. She worked for 17 years in clinical organ transplant immunology laboratories. Her dissertation project focused on novel targets in TNF-alpha and IL-6 inflammatory cytokine signaling. Ruby is a member of American Society for Histocompatibility and Immunogenetics, American Association of Immunologists, and the American College of Rheumatology. She was awarded the Rheumatology Research Foundation Graduate Student Preceptorship Award and an NIH F31 Predoctoral Fellowship.